AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study 36165994 — intervention group
Group type: EXPERIMENTAL
Intervention: Jump training with overhead goal (OG)
Number of subjects: 52
Study 36165994 — intervention group
Group type: COMPARATOR
Intervention: Jump training without overhead goal (OG)
Number of subjects: 52
Study 36165994 — intervention group
Group type: COMPARATOR
Intervention: Untrained group
Number of subjects: 52
Study 34244155 — intervention group
Group type: EXPERIMENTAL
Intervention: ω‐3‐FA (3.25 g/day combined EPA and DHA)
Number of subjects: 46
Study 34244155 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 46
Study 34244155 — intervention group
Group type: EXPERIMENTAL
Intervention: ω‐3‐FA
Number of subjects: 46
Study 34244155 — intervention group
Group type: EXPERIMENTAL
Intervention: ω‐3‐FA (for those with >10% weight loss)
Number of subjects: 46
Study 32908891 — intervention group
Group type: EXPERIMENTAL
Intervention: CLOCK gene rs1801260 (TC) and positive psychological symptoms
Number of subjects: 521
Study 32908891 — intervention group
Group type: EXPERIMENTAL
Intervention: CLOCK gene rs1801260 (TT)
Number of subjects: 521
Study 32908891 — intervention group
Group type: EXPERIMENTAL
Intervention: Positive psychological symptoms
Number of subjects: 521
Study 32908891 — intervention group
Group type: EXPERIMENTAL
Intervention: Demographic characteristics
Number of subjects: 521
Study 32908891 — intervention group
Group type: EXPERIMENTAL
Intervention: Different genotypes at CLOCK rs1801260 and rs6850524
Number of subjects: 521
Study 35681224 — intervention group
Group type: EXPERIMENTAL
Intervention: MULTIPAP Plus intervention
Number of subjects: 1148
Study 35681224 — intervention group
Group type: COMPARATOR
Intervention: Usual care
Number of subjects: 1148
Study 35148588 — intervention group
Group type: EXPERIMENTAL
Intervention: Low-pressure pneumoperitoneum (LP; 8 mmHg)
Number of subjects: 62
Study 35148588 — intervention group
Group type: COMPARATOR
Intervention: Standard-pressure pneumoperitoneum (SP; 14 mmHg)
Number of subjects: 62
Study 35148588 — intervention group
Group type: EXPERIMENTAL
Intervention: Both groups (LP and SP)
Number of subjects: 62
Study 32448781 — intervention group
Group type: EXPERIMENTAL
Intervention: Facilitator-mediated implementation package (group A)
Number of subjects: 55
Study 32448781 — intervention group
Group type: EXPERIMENTAL
Intervention: Self-directed implementation package (group B)
Number of subjects: 55
Study 32448781 — intervention group
Group type: COMPARATOR
Intervention: Usual care (control) (group C)
Number of subjects: 55
Study 34363762 — intervention group
Group type: EXPERIMENTAL
Intervention: Avelumab maintenance (10 mg/kg intravenously every 2 weeks)
Number of subjects: 998
Study 34363762 — intervention group
Group type: EXPERIMENTAL
Intervention: Avelumab combination (10 mg/kg intravenously every 3 weeks)
Number of subjects: 998
Study 34363762 — intervention group
Group type: COMPARATOR
Intervention: Control (chemotherapy followed by observation)
Number of subjects: 998
Study 35964041 — intervention group
Group type: EXPERIMENTAL
Intervention: LH-based flexible GnRH antagonist protocol
Number of subjects: 216
Study 35964041 — intervention group
Group type: COMPARATOR
Intervention: Traditional flexible GnRH antagonist protocol
Number of subjects: 216
Study 33982405 — intervention group
Group type: EXPERIMENTAL
Intervention: Difelikefalin 1.0 mcg/kg i.v.
Number of subjects: 15
Study 33982405 — intervention group
Group type: EXPERIMENTAL
Intervention: Difelikefalin 5.0 mcg/kg i.v.
Number of subjects: 15
Study 33982405 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 15
Study 32241693 — intervention group
Group type: EXPERIMENTAL
Intervention: Adjuvant targeted therapy (TT)
Number of subjects: 41027
Study 32241693 — intervention group
Group type: COMPARATOR
Intervention: No adjuvant targeted therapy (TT)
Number of subjects: 41027
Study 36253020 — intervention group
Group type: EXPERIMENTAL
Intervention: Self-management Programme of Activity, Coping and Education (SMP) delivered in groups over 5 months
Number of subjects: 193
Study 34050550 — intervention group
Group type: EXPERIMENTAL
Intervention: E-PsEYE intervention (internet-based guided self-help course)
Number of subjects: 90
Study 33113552 — intervention group
Group type: EXPERIMENTAL
Intervention: Nivolumab (anti-PD1) first-line therapy
Number of subjects: 0
Study 33033014 — intervention group
Group type: EXPERIMENTAL
Intervention: Endotracheal tube plus stylet
Number of subjects: 0
Study 33033014 — intervention group
Group type: COMPARATOR
Intervention: Endotracheal tube alone (control group)
Number of subjects: 0
Study 35997971 — intervention group
Group type: EXPERIMENTAL
Intervention: Citalopram
Number of subjects: 91
Study 35997971 — intervention group
Group type: COMPARATOR
Intervention: Fluoxetine
Number of subjects: 91
Study 33257276 — intervention group
Group type: EXPERIMENTAL
Intervention: Movement System Impairment‐Based classification model (MSI)
Number of subjects: 0
Study 33257276 — intervention group
Group type: COMPARATOR
Intervention: Stretching and strengthening exercises for chronic LBP
Number of subjects: 0
Study 32917317 — intervention group
Group type: EXPERIMENTAL
Intervention: PPE 400 mg per day
Number of subjects: 100
Study 32917317 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 100
Study 36094202 — intervention group
Group type: COMPARATOR
Intervention: Ensitrelvir 20, 70, 250, 500, 1,000, or 2,000 mg (part 1)
Number of subjects: 83
Study 36094202 — intervention group
Group type: COMPARATOR
Intervention: Ensitrelvir 375/125 mg or 750/250 mg once daily for 5 days (part 2)
Number of subjects: 83
Study 36094202 — intervention group
Group type: EXPERIMENTAL
Intervention: Ensitrelvir 750/250 mg coadministered with midazolam
Number of subjects: 83
Study 36094202 — intervention group
Group type: COMPARATOR
Intervention: Placebo (part 1 and part 2)
Number of subjects: 83
Study 36094202 — intervention group
Group type: EXPERIMENTAL
Intervention: Food intake effect on ensitrelvir
Number of subjects: 83
Study 32315330 — intervention group
Group type: EXPERIMENTAL
Intervention: Hyperoxic conditions
Number of subjects: 25
Study 32315330 — intervention group
Group type: COMPARATOR
Intervention: Normoxic conditions
Number of subjects: 25
Study 35705512 — intervention group
Group type: EXPERIMENTAL
Intervention: Fast Track intervention
Number of subjects: 400
Study 35705512 — intervention group
Group type: COMPARATOR
Intervention: Control group
Number of subjects: 400
Study 34740265 — intervention group
Group type: EXPERIMENTAL
Intervention: Collagen barrier (Test group)
Number of subjects: 94
Study 34740265 — intervention group
Group type: COMPARATOR
Intervention: No collagen barrier (Control group)
Number of subjects: 94
Study 33402623 — intervention group
Group type: EXPERIMENTAL
Intervention: Tell-show-do technique with the aid of a virtual tool
Number of subjects: 90
Study 33402623 — intervention group
Group type: COMPARATOR
Intervention: Tell-show-do technique without the aid of a virtual tool
Number of subjects: 90
Study 32396614 — intervention group
Group type: EXPERIMENTAL
Intervention: Autologous stem-cell transplant (ASCT) after first relapse
Number of subjects: 478
Study 35166054 — intervention group
Group type: EXPERIMENTAL
Intervention: SAR342434 insulin lispro
Number of subjects: 36
Study 35166054 — intervention group
Group type: COMPARATOR
Intervention: Humalog insulin lispro
Number of subjects: 36
Study 33518076 — intervention group
Group type: EXPERIMENTAL
Intervention: Cage-free housing (CF)
Number of subjects: 50
Study 33518076 — intervention group
Group type: COMPARATOR
Intervention: Conventional cages (CC)
Number of subjects: 50
Study 32195731 — intervention group
Group type: EXPERIMENTAL
Intervention: AI-enabled fluoroscopy system
Number of subjects: 100
Study 32195731 — intervention group
Group type: COMPARATOR
Intervention: Conventional fluoroscopy system
Number of subjects: 100
Study 35477870 — intervention group
Group type: EXPERIMENTAL
Intervention: Supervised physical activity intervention
Number of subjects: 124
Study 35477870 — intervention group
Group type: COMPARATOR
Intervention: Control group (not specified in detail)
Number of subjects: 124
Study 32122626 — intervention group
Group type: EXPERIMENTAL
Intervention: Conventional microbiological cultures
Number of subjects: 137
Study 32122626 — intervention group
Group type: EXPERIMENTAL
Intervention: Staphylococcus aureus
Number of subjects: 137
Study 32122626 — intervention group
Group type: EXPERIMENTAL
Intervention: Coagulase-negative Staphylococcus
Number of subjects: 137
Study 32122626 — intervention group
Group type: EXPERIMENTAL
Intervention: Staphylococcus epidermidis
Number of subjects: 137
Study 32122626 — intervention group
Group type: EXPERIMENTAL
Intervention: Methicillin-resistant S. aureus (MRSA)
Number of subjects: 137
Study 33894327 — intervention group
Group type: EXPERIMENTAL
Intervention: Golexanolone (10, 40 or 80 mg BID)
Number of subjects: 45
Study 33894327 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 45
Study 33079152 — intervention group
Group type: EXPERIMENTAL
Intervention: 15-mg/d vericiguat
Number of subjects: 789
Study 33079152 — intervention group
Group type: EXPERIMENTAL
Intervention: 10-mg/d vericiguat
Number of subjects: 789
Study 33079152 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 789
Study 34653328 — intervention group
Group type: EXPERIMENTAL
Intervention: Liquid L-thyroxine (T4® drops)
Number of subjects: 39
Study 34653328 — intervention group
Group type: COMPARATOR
Intervention: Tablets L-thyroxine (T4® tablets)
Number of subjects: 39
Study 34893133 — intervention group
Group type: EXPERIMENTAL
Intervention: Calcitriol combined with sirolimus
Number of subjects: 146
Study 34893133 — intervention group
Group type: COMPARATOR
Intervention: Sirolimus (control group)
Number of subjects: 146
Study 35232647 — intervention group
Group type: EXPERIMENTAL
Intervention: UDCA
Number of subjects: 152
Study 35232647 — intervention group
Group type: EXPERIMENTAL
Intervention: Digestive Enzyme
Number of subjects: 152
Study 36036664 — intervention group
Group type: COMPARATOR
Intervention: Implementation strategies (educational materials, educational outreach, educational meetings)
Number of subjects: 1917
Study 36036664 — intervention group
Group type: COMPARATOR
Intervention: Implementation strategies
Number of subjects: 1917
Study 33174636 — intervention group
Group type: EXPERIMENTAL
Intervention: Ultrasound (US) evaluation for high-grade lacerations
Number of subjects: 32
Study 33174636 — intervention group
Group type: EXPERIMENTAL
Intervention: Magnetic Resonance Imaging (MRI) evaluation for high-grade lacerations
Number of subjects: 32
Study 32610351 — intervention group
Group type: EXPERIMENTAL
Intervention: Multimodal approach (mCM) using navigated task-specific fMRI and direct cortical stimulation (DCS)
Number of subjects: 21
Study 32610351 — intervention group
Group type: COMPARATOR
Intervention: Electrical cortical mapping (eCM) using DCS alone
Number of subjects: 21
Study 32610351 — intervention group
Group type: EXPERIMENTAL
Intervention: DCS with nfMRI
Number of subjects: 21
Study 33180542 — intervention group
Group type: EXPERIMENTAL
Intervention: Alcohol consumption (target BAC = .08%)
Number of subjects: 258
Study 33180542 — intervention group
Group type: EXPERIMENTAL
Intervention: High arousal positive (HIGH+) expectancies
Number of subjects: 258
Study 33180542 — intervention group
Group type: EXPERIMENTAL
Intervention: High arousal negative (HIGH-) expectancies
Number of subjects: 258
Study 33180542 — intervention group
Group type: COMPARATOR
Intervention: Control for prior drinking
Number of subjects: 258
Study 34886117 — intervention group
Group type: EXPERIMENTAL
Intervention: Mobile and internet-based aftercare program including psychoeducation, individual crisis plan, optional counseling via internet chat or phone, and supportive monitoring module.
Number of subjects: 25
Study 34886117 — intervention group
Group type: EXPERIMENTAL
Intervention: Mobile and internet-based aftercare program
Number of subjects: 25
Study 34886117 — intervention group
Group type: COMPARATOR
Intervention: Recruitment process
Number of subjects: 25
Study 32736555 — intervention group
Group type: EXPERIMENTAL
Intervention: Experiential Learning (EL) intervention, which included a lively presentation on oral health and role play in a simulated dental clinic.
Number of subjects: 988
Study 32736555 — intervention group
Group type: COMPARATOR
Intervention: Tell-Show-Do (TSD) control group, which involved conventional behavior management.
Number of subjects: 988
Study 32736555 — intervention group
Group type: EXPERIMENTAL
Intervention: Experiential Learning (EL) intervention
Number of subjects: 988
Study 35614590 — intervention group
Group type: EXPERIMENTAL
Intervention: Static stretching with range of motion
Number of subjects: 30
Study 35614590 — intervention group
Group type: COMPARATOR
Intervention: Routine post-operative care
Number of subjects: 30
Study 33326555 — intervention group
Group type: EXPERIMENTAL
Intervention: Oil-soluble contrast media (OSCM) for hysterosalpingography (HSG)
Number of subjects: 0
Study 33326555 — intervention group
Group type: COMPARATOR
Intervention: Water-soluble contrast media (WSCM)
Number of subjects: 0
Study 36451510 — intervention group
Group type: EXPERIMENTAL
Intervention: Self-gravitation traction at 40% or 60% of body weight
Number of subjects: 0
Study 36451510 — intervention group
Group type: COMPARATOR
Intervention: Self-gravitation traction at 20% of body weight (control)
Number of subjects: 0
Study 35078520 — intervention group
Group type: EXPERIMENTAL
Intervention: Pediatric Tuina plus conventional treatment
Number of subjects: 0
Study 35078520 — intervention group
Group type: COMPARATOR
Intervention: Conventional treatment alone
Number of subjects: 0
Study 32620155 — intervention group
Group type: EXPERIMENTAL
Intervention: β‐sitosterol enriched saw palmetto oil
Number of subjects: 99
Study 32620155 — intervention group
Group type: COMPARATOR
Intervention: Conventional saw palmetto oil
Number of subjects: 99
Study 32620155 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 99
Study 36114133 — intervention group
Group type: COMPARATOR
Intervention: Control group (optimal nonpharmacologic therapy)
Number of subjects: 48
Study 34400398 — intervention group
Group type: EXPERIMENTAL
Intervention: Mandatory CEL activities
Number of subjects: 15
Study 34400398 — intervention group
Group type: EXPERIMENTAL
Intervention: Voluntary CEL activities
Number of subjects: 15
Study 34400398 — intervention group
Group type: EXPERIMENTAL
Intervention: Mandatory and voluntary CEL activities
Number of subjects: 15
Study 34400398 — intervention group
Group type: EXPERIMENTAL
Intervention: Barriers to engagement
Number of subjects: 15
Study 35349214 — intervention group
Group type: EXPERIMENTAL
Intervention: Single bolus of 1 mmol/kg 23.4% sodium chloride (Group 1)
Number of subjects: 33
Study 35349214 — intervention group
Group type: EXPERIMENTAL
Intervention: Split bolus of 0.5 mmol/kg 23.4% sodium chloride (Group 2)
Number of subjects: 33
Study 35349214 — intervention group
Group type: COMPARATOR
Intervention: Comparison of pain between groups
Number of subjects: 33
Study 35349214 — intervention group
Group type: COMPARATOR
Intervention: Comparison of IOP reduction between groups
Number of subjects: 33
Study 32789723 — intervention group
Group type: EXPERIMENTAL
Intervention: Flare covered self-expandable metal stent (SEMS)
Number of subjects: 60
Study 32789723 — intervention group
Group type: COMPARATOR
Intervention: ComVi double-layered covered self-expandable metal stent (SEMS)
Number of subjects: 60
Study 34557956 — intervention group
Group type: EXPERIMENTAL
Intervention: Photobiomodulation (PBM) therapy
Number of subjects: 14
Study 34557956 — intervention group
Group type: COMPARATOR
Intervention: Sham PBM therapy
Number of subjects: 14
Study 34557956 — intervention group
Group type: COMPARATOR
Intervention: Both groups (PBM and Sham)
Number of subjects: 14
Study 34557956 — intervention group
Group type: EXPERIMENTAL
Intervention: PBM therapy
Number of subjects: 14
Study 34557956 — intervention group
Group type: COMPARATOR
Intervention: Sham therapy
Number of subjects: 14
Study 34032882 — intervention group
Group type: EXPERIMENTAL
Intervention: Tracheal tube + stylet
Number of subjects: 999
Study 34032882 — intervention group
Group type: COMPARATOR
Intervention: Tracheal tube alone
Number of subjects: 999
Study 32075612 — intervention group
Group type: EXPERIMENTAL
Intervention: TPB-based education intervention conducted in four educational sessions over 1 month.
Number of subjects: 100
Study 32075612 — intervention group
Group type: EXPERIMENTAL
Intervention: TPB-based education intervention
Number of subjects: 100
Study 32075612 — intervention group
Group type: COMPARATOR
Intervention: Control group (no educational intervention)
Number of subjects: 100
Study 36259747 — intervention group
Group type: EXPERIMENTAL
Intervention: High-intensity interval training (HIIT) with Indigenous narrative options
Number of subjects: 368
Study 36259747 — intervention group
Group type: COMPARATOR
Intervention: Standard curriculum physical education practice
Number of subjects: 368
Study 33206400 — intervention group
Group type: EXPERIMENTAL
Intervention: Counselling programme plus jaw exercises
Number of subjects: 70
Study 33206400 — intervention group
Group type: COMPARATOR
Intervention: Counselling programme
Number of subjects: 70
Study 33206400 — intervention group
Group type: COMPARATOR
Intervention: Comparison between counselling programme and counselling plus jaw exercises
Number of subjects: 70
Study 35942923 — intervention group
Group type: EXPERIMENTAL
Intervention: High-Intensity Interval Training (HIIT; 1-min bouts at 100% WRpeak, 3 sessions/week for 8 weeks)
Number of subjects: 20
Study 35942923 — intervention group
Group type: COMPARATOR
Intervention: Moderate-Intensity Continuous Training (MICT; 50% peak work rate)
Number of subjects: 20
Study 32872012 — intervention group
Group type: EXPERIMENTAL
Intervention: Gualou Danshen granules (GLDS)
Number of subjects: 60
Study 32872012 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 60
Study 34270471 — intervention group
Group type: EXPERIMENTAL
Intervention: Carpal Tunnel Syndrome (CTS) patients
Number of subjects: 9442
Study 34270471 — intervention group
Group type: COMPARATOR
Intervention: Controls (no CTS)
Number of subjects: 9442
Study 34270471 — intervention group
Group type: EXPERIMENTAL
Intervention: Risk factors for CTS
Number of subjects: 9442
Study 32954647 — intervention group
Group type: EXPERIMENTAL
Intervention: Qishen Yiqi dripping pills (QSYQ) for 6 months
Number of subjects: 640
Study 32954647 — intervention group
Group type: COMPARATOR
Intervention: Placebo for 6 months
Number of subjects: 640
Study 32954647 — intervention group
Group type: EXPERIMENTAL
Intervention: Qishen Yiqi dripping pills (QSYQ)
Number of subjects: 640
Study 32954647 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 640
Study 33907224 — intervention group
Group type: EXPERIMENTAL
Intervention: Paracetamol 1 g tablet formulation
Number of subjects: 36
Study 32404279 — intervention group
Group type: EXPERIMENTAL
Intervention: Transcutaneous auricular vagus nerve stimulation (taVNS)
Number of subjects: 39
Study 32969469 — intervention group
Group type: EXPERIMENTAL
Intervention: Educated group (133 patients)
Number of subjects: 263
Study 32969469 — intervention group
Group type: COMPARATOR
Intervention: Control group (130 patients)
Number of subjects: 263
Study 34488845 — intervention group
Group type: EXPERIMENTAL
Intervention: Low-cell dose treatment group (n = 30)
Number of subjects: 90
Study 34488845 — intervention group
Group type: EXPERIMENTAL
Intervention: High-cell dose treatment group (n = 30)
Number of subjects: 90
Study 34488845 — intervention group
Group type: COMPARATOR
Intervention: Control group (n = 30)
Number of subjects: 90
Study 34488845 — intervention group
Group type: EXPERIMENTAL
Intervention: All groups (including control)
Number of subjects: 90
Study 32013106 — intervention group
Group type: EXPERIMENTAL
Intervention: Sport Education (n = 74)
Number of subjects: 148
Study 32013106 — intervention group
Group type: COMPARATOR
Intervention: Traditional Teaching (n = 74)
Number of subjects: 148
Study 35227127 — intervention group
Group type: EXPERIMENTAL
Intervention: Pro-environmental prenatal education program
Number of subjects: 96
Study 35659571 — intervention group
Group type: EXPERIMENTAL
Intervention: Response-adjusted protocol (n=27) with tapering doses of prednisone over 8 weeks
Number of subjects: 59
Study 35659571 — intervention group
Group type: COMPARATOR
Intervention: Usual care group (n=32) with standard protocol (60 mg/m2/24 hours for 6 weeks, followed by 40 mg/m2/48 hours for 4 weeks, followed by a slow taper for a total of 24 weeks)
Number of subjects: 59
Study 35793466 — intervention group
Group type: EXPERIMENTAL
Intervention: Straight-tip guidewire
Number of subjects: 88
Study 35793466 — intervention group
Group type: COMPARATOR
Intervention: J-tip guidewire
Number of subjects: 88
Study 34273257 — intervention group
Group type: EXPERIMENTAL
Intervention: Apalutamide-applesauce mixture
Number of subjects: 12
Study 34273257 — intervention group
Group type: COMPARATOR
Intervention: Whole tablets of apalutamide
Number of subjects: 12
Study 32103926 — intervention group
Group type: EXPERIMENTAL
Intervention: Budesonide/Glycopyrrolate/Formoterol Fumarate (BUD/GLY/FORM) triple therapy
Number of subjects: 19
Study 32103926 — intervention group
Group type: COMPARATOR
Intervention: Budesonide/Formoterol Fumarate (BUD/FORM) dual therapy
Number of subjects: 19
Study 32103926 — intervention group
Group type: COMPARATOR
Intervention: Run-in period
Number of subjects: 19
Study 32103926 — intervention group
Group type: EXPERIMENTAL
Intervention: BUD/GLY/FORM triple therapy
Number of subjects: 19
Study 34450102 — intervention group
Group type: EXPERIMENTAL
Intervention: Autologous HSCT (myeloablative radiochemotherapy followed by autologous HSCT)
Number of subjects: 269
Study 34450102 — intervention group
Group type: COMPARATOR
Intervention: Interferon alfa maintenance (6 × 106 IU three times a week subcutaneously until progression)
Number of subjects: 269
Study 32393320 — intervention group
Group type: EXPERIMENTAL
Intervention: Usual care including home exercise (UCHE) plus spa therapy (18 days of mud packs, underwater massages, showers and water exercises under medical supervision)
Number of subjects: 358
Study 32393320 — intervention group
Group type: COMPARATOR
Intervention: Usual care including home exercise (UCHE) alone
Number of subjects: 358
Study 32393320 — intervention group
Group type: EXPERIMENTAL
Intervention: UCHE plus spa therapy
Number of subjects: 358
Study 32393320 — intervention group
Group type: COMPARATOR
Intervention: UCHE alone
Number of subjects: 358
Study 32370582 — intervention group
Group type: EXPERIMENTAL
Intervention: Indirect questioning about the acceptability of wife-beating
Number of subjects: 809
Study 32370582 — intervention group
Group type: COMPARATOR
Intervention: Direct questioning about the acceptability of wife-beating
Number of subjects: 809
Study 32370582 — intervention group
Group type: EXPERIMENTAL
Intervention: Participants with less education (<3 years schooling)
Number of subjects: 809
Study 32370582 — intervention group
Group type: EXPERIMENTAL
Intervention: Participants living in households where women do not participate in economic decision making
Number of subjects: 809
Study 32370582 — intervention group
Group type: EXPERIMENTAL
Intervention: Adults with higher levels of education
Number of subjects: 809